Targeted Microbiome Transplant in Atopic Dermatitis
Status:
Completed
Trial end date:
2019-06-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and effectiveness of a new therapy,
commensal lotion containing infection fighting bacteria, on decreasing or eliminating the
infection causing bacteria found on the skin of Atopic Dermatitis (AD) patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)